1. Home
  2. JCSE vs HCWB Comparison

JCSE vs HCWB Comparison

Compare JCSE & HCWB Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo JE Cleantech Holdings Limited

JCSE

JE Cleantech Holdings Limited

HOLD

Current Price

$1.10

Market Cap

5.9M

ML Signal

HOLD

Logo HCW Biologics Inc.

HCWB

HCW Biologics Inc.

HOLD

Current Price

$1.85

Market Cap

5.5M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
JCSE
HCWB
Founded
1999
2018
Country
Singapore
United States
Employees
N/A
N/A
Industry
Miscellaneous manufacturing industries
Biotechnology: Pharmaceutical Preparations
Sector
Consumer Discretionary
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
5.9M
5.5M
IPO Year
2022
2021

Fundamental Metrics

Financial Performance
Metric
JCSE
HCWB
Price
$1.10
$1.85
Analyst Decision
Strong Buy
Analyst Count
0
1
Target Price
N/A
$35.00
AVG Volume (30 Days)
3.8K
141.6K
Earning Date
10-30-2025
11-14-2025
Dividend Yield
8.14%
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
$11,804,296.00
$422,026.00
Revenue This Year
N/A
$178.64
Revenue Next Year
N/A
N/A
P/E Ratio
N/A
N/A
Revenue Growth
N/A
N/A
52 Week Low
$0.86
$1.84
52 Week High
$1.75
$41.20

Technical Indicators

Market Signals
Indicator
JCSE
HCWB
Relative Strength Index (RSI) 40.97 32.11
Support Level $1.09 $1.89
Resistance Level $1.16 $2.15
Average True Range (ATR) 0.02 0.16
MACD -0.00 0.05
Stochastic Oscillator 0.00 2.08

Price Performance

Historical Comparison
JCSE
HCWB

About JCSE JE Cleantech Holdings Limited

JE Cleantech Holdings Ltd is engaged in the manufacturing and selling of cleaning systems and other equipment that can be categorized into four different categories, namely aqueous washing systems, plating and cleaning systems, train cleaning systems, and other equipment, such as filtration units. The product lives of its cleaning systems and other equipment ranges from two to ten years. The company is also into designing, developing, and manufacturing other cleaning systems for various industrial end-use applications using its R&D and engineering capabilities. The company derives the majority of its revenue from the Sales of cleaning systems and other equipment. Geographically, the company derives a majority of its revenue from Singapore, followed by Malaysia.

About HCWB HCW Biologics Inc.

HCW Biologics Inc is a clinical-stage biopharmaceutical company focused on discovering and developing novel immunotherapies to lengthen the health span by disrupting the link between chronic, low-grade inflammation and age-related diseases. The company has developed TOBI discovery platform, or Tissue factor-based fusion discovery platform, for the design of category-defining immunotherapeutic drugs. It has selected two molecules as its product candidate; HCW9218 and HCW9302. HCW9218 is a bifunctional immunotherapeutic designed with the capabilities to neutralize transforming growth and stimulate immune cells. HCW9302 is designed to activate and expand regulatory T cells, which deactivate inflammasomes.

Share on Social Networks: